Logo

BioFocus Granted ISO Certification Extension for Dutch Operations

Nov 29, 2006
NEW YORK (GenomeWeb News) — Galapagos’ BioFocus DPI division today said it has received an extension of its certification from the International Standards Organization for its target discovery operations in its Leiden, the Netherlands.
 
BioFocus, which specializes in adenoviral agents and compound libraries for drug development, said the certification covers the chemical and biological research services it offers to pharma, biotech and agrochem businesses.
 
This marks an extension of an ISO certification the company’s Cambridge, UK operation received in 2003.

Breaking News
The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.